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Report
Schizophrenia and Affective Disorders—Cosegregation with a
Translocation at Chromosome 1q42 That Directly Disrupts Brain-Expressed
Genes: Clinical and P300 Findings in a Family
D. H. R. Blackwood,1,2 A. Fordyce,3 M. T. Walker,1 D. M. St. Clair,4 D. J. Porteous,2 and
W. J. Muir1,2
1University Department of Psychiatry, Royal Edinburgh Hospital, 2University of Edinburgh, Medical Genetics Section, Molecular Medicine
Centre, and 3MRC Human Genetics Unit, Western General Hospital, Edinburgh; and 4University of Aberdeen, Department of Mental Health,
Royal Cornhill Hospital, Aberdeen, Scotland
A family with a (1;11)(q42;q14.3) translocation significantly linked to a clinical phenotype that includes schizo-
phrenia and affective disorders is described. This translocation generates a LOD score of 3.6 when the disease
phenotype is restricted to schizophrenia, of 4.5 when the disease phenotype is restricted to affective disorders, of
7.1 when relatives with recurrent major depression, with bipolar disorder, or with schizophrenia are all classed as
affected. This evidence for linkage is among the strongest reported for a psychiatric disorder. Family members
showed no distinctive features by which the psychiatric phenotype could be distinguished from unrelated cases of
either schizophrenia or affective disorders, and no physical, neurological, or dysmorphic conditions co-occurred
with psychiatric symptoms. Translocation carriers and noncarriers had the same mean intelligence quotient. Trans-
location carriers were similar to subjects with schizophrenia and different from noncarriers and controls, in showing
a significant reduction in the amplitude of the P300 event-related potential (ERP). Furthermore, P300 amplitude
reduction and latency prolongation were measured in some carriers of the translocation who had no psychiatric
symptoms—a pattern found in other families with multiple members with schizophrenia, in which amplitude of
and latency of P300 appear to be trait markers of risk. The results of karyotypic, clinical, and ERP investigations
of this family suggest that the recently described genes DISC1 and DISC2, which are directly disrupted by the
breakpoint on chromosome 1, may have a role in the development of a disease phenotype that includes schizophrenia
as well as unipolar and bipolar affective disorders.
Schizophrenia (MIM 181500), bipolar disorder (MIM
125480), and recurrent major depression (i.e., unipolar
disorder) are among the most prevalent causes of dis-
ability worldwide (Lopez and Murray 1998). Family
and twin research has established the importance of
inherited factors, and several chromosomal regions
likely to harbor susceptibility genes have been identified
during 10 years of extensive linkage and association
studies (Potash and DePaulo 2000; Riley and McGuffin
2000). At several chromosomal locations—including
13q, 18p, and 22q—linkage has been reported to both
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schizophrenia and bipolar disorder, raising the possi-
bility that some genetic risk factors contribute to a
range of psychotic symptoms and give rise to pheno-
types that cross the traditional diagnostic boundaries
of schizophrenia and of affective disorders (Wildenauer
et al. 1999; Berrettini 2000). However, it is not clear,
given the large number of linkage reports for both dis-
orders, that the number of regions with positive results
with regard to schizophrenia and bipolar disorder ex-
ceeds chance expectation. Whereas most family and
twin studies do not support coaggregation of these dis-
orders, some family studies have reported overlap of
predisposition to schizophrenia and affective disorders
(Maier et al. 1993). We describe the clinical phenotypes
found in a large family in which a balanced translo-
cation—(1;11)(q42;q14.3)—that disrupts two novel
brain-expressed genes cosegregates with major psychi-
atric disorders. Clinical diagnoses in family members
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Figure 1 Part of the family with a (1;11)(q42;q14.3) translocation. Karyotype analysis has been performed on 87 members of this family,
and clinical psychiatric data were obtained from 69 of those family members. Shown are 58 of the family members for whom carrier status is
known and whose psychiatric phenotype has been defined through follow-up by direct interview, general-practice contact, or hospital case-note
review.
were based on DSM-IV criteria derived from a standard
interview and from a case-note review. The phenotype
was also investigated in a subgroup of family members,
by measurement of intelligence quotient (IQ) and the
auditory P300 event-related potential (ERP), which has
been shown to be abnormal in patients with schizo-
phrenia and in their unaffected relatives and is a pu-
tative trait marker of risk for schizophrenia (Black-
wood et al. 1991; Sham et al. 1994; Weisbrod et al.
1999).
This family was first ascertained by Jacobs et al.
(1970), who reported the translocation in the proposi-
tus, who had adolescent conduct disorder, and in mem-
bers of four generations of the propositus’s extended
family. Follow-up of the family over 20 years revealed
an increased incidence of major psychiatric disorders,
including schizophrenia and recurrent major depression,
among relatives with the translocation and found no
cases of these disorders in relatives with a normal kar-
yotype (St. Clair et al. 1990). It was proposed that dis-
ruption of one or more genes at or near one of the
translocation breakpoints increased the risk of devel-
opment of psychosis in this family. Over the past 10
years, members of this family have been systematically
followed up by direct interview, regular contact with
general practitioners, or hospital case-note review. The
study has been approved by the local Ethics of Research
Committee, and family members have given informed,
written consent. Interviews were conducted by experi-
enced psychiatrists (D.H.R.B., W.J.M., and D.St.C.) us-
ing the Schedule for Affective Disorders and Schizophre-
nia L (Endicott and Spitzer 1978); consensus diagnoses
blind to carrier status and based on DSM-IV criteria are
shown in figure 1. Of the 87 members of the family who
were karyotyped, 37 carried the translocation. Of the
50 noncarriers, 18 were married-in relatives. Living rel-
atives were interviewed directly by a psychiatrist, and
deceased members were included in the analysis if ad-
equate hospital and general-practice case records were
available. A psychiatric diagnosis was reached for 29
carriers, 38 noncarriers, and the 2 founders (who were
not karyotyped).
Figure 1 shows the family members for whom psy-
chiatric assessment was possible and for whom karyo-
type status was available. To preserve the anonymity of
family members, 11 individuals with a normal karyotype
and without a psychiatric diagnosis (all were siblings of
carriers) have been omitted from the figure but were
included in the linkage analysis.
Nine new cases of major psychiatric disorder have
been diagnosed during the follow-up period over the
past 10 years. Of note is a relative (IV:17) with bipolar
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Table 1
Linkage of t(1;11) to Schizophrenia and Affective Disorders
PHENOTYPEa
GENE
FREQUENCYb PENETRANCE
LOD SCORE AT v p
0 .05 .1 .2
Model 1 .004 .2 3.6 3.3 3.0 2.3
Model 2 .03 .3 4.5 4.0 3.6 2.7
Model 3 .03 .5 7.1 6.6 5.9 4.6
Model 4 .1 .6 1.9 2.5 2.6 2.4
a Linkage analysis was performed by MLINK, under the assumption
of dominant inheritance, for four definitions of the disease phenotype
(Terwilliger and Ott 1994): model 1 p 7 cases of schizophrenia (all
other diagnoses coded as unknown); model 2p 11 cases of recurrent
major depression and 1 case of bipolar disorder (schizophrenia and
other diagnoses coded as unknown); model 3 p schizophrenia, re-
current major depression, and bipolar disorder; model 4 p all diag-
noses, including alcoholism, minor depression, anxiety, and adolescent
conduct-and-emotional disorder.
b Gene frequencies were compatible with the assumption of a life-
time risk of .006 for schizophrenia or of .05 for major affective dis-
orders; the translocation was assumed to be rare in the population,
with frequency .00001.
disorder whose child (V:10) developed a chronic schiz-
ophrenic disorder. For the 29 subjects with the trans-
location, the following diagnoses were made: schizo-
phrenia (in 7 cases), bipolar disorder (in 1 case),
recurrent major depression (in 10 cases), adolescent con-
duct-and-emotional disorder (in 2 cases), and minor de-
pression (in 1 case). The propositus and two siblings
were the only members of the extended pedigree who
were diagnosed with severe adolescent conduct-and-
emotional disorder, and, because one of these siblings
had a normal karyotype, adolescent disorder appears to
be unrelated to the translocation. No major psychiatric
disorder was diagnosed in 38 relatives with a normal
karyotype. In this group, psychiatric diagnoses were as
follows: adolescent conduct-and-emotional disorder (in
one case), minor depression (in three cases), and alco-
holism (in one case). A maximum LOD score of 7.1
confirmed close linkage of the translocation to the clin-
ical phenotype that included schizophrenia, bipolar dis-
order, and recurrent major depression (table 1). Linkage
between the translocation and major affective disorder
(LOD score 4.5) was also confirmed in an analysis in
which only the cases of recurrent major depression and
the single case of bipolar disorder were coded as affected
and in which the seven cases of schizophrenia were
coded as unknown. Linkage with schizophrenia alone
was also significant (LOD score 3.6) in an analysis that
included the seven cases of schizophrenia and that coded
other disorders as unknown. These are among the high-
est LOD scores reported, to date, for linkage to either
schizophrenia or affective disorders.
Single-family studies are important for the identifica-
tion of the group of psychoses in which single-gene loci
may have a major effect on illness risk. However, findings
may be unique to one family, and, because the translo-
cation is rare, it is important to investigate possible phe-
notype differences between members of this family and
unrelated individuals with either schizophrenia or affec-
tive disorders. Direct interviews as well as hospital and
general-practice case-note reviews confirmed that the
translocation was not associated with any physical or neu-
rological illnesses, developmental abnormalities, or dys-
morphisms, and the IQs of the family members, measured
by the National Adult Reading Test, were within the nor-
mal range. There was no difference in the mean IQ of 12
relatives with the translocation (mean IQ 100.3) and 8
relatives with a normal karyotype (mean IQ 100.5). Dur-
ing the follow-up period, the auditory P300 ERP of 12
relatives with the translocation, 10 noncarriers, 20 un-
related subjects with schizophrenia, and 26 controls—all
of age 18–60 years—was recorded, to compare the phe-
notypes in members of this family and unrelated subjects.
Prolonged latency of and reduced amplitude of P300 ERP,
which have consistently been found in patients with
schizophrenia and in their relatives, are thought to indi-
cate deficits in the speed and the efficiency of the pro-
cessing of stimuli in short-term memory and may be con-
sidered trait markers of risk (Schreiber et al. 1992;
Blackwood 2000). Changes in the latency and the am-
plitude of P300 are also found in patients with bipolar
disorder (Muir et al. 1991), but there are differences be-
tween patients with schizophrenia and patients with af-
fective disorders, in the topography of the amplitude re-
duction (Salisbury et al. 1999). P300 is normal in
recurrent major depression, although, in families with
multiple members with schizophrenia, relatives who have
recurrent major depression may show the same P300 ab-
normalities as do their relatives with schizophrenia
(Blackwood et al. 1991). As described by Souza et al.
(1995), recordings were made from three midline sites
(frontal, central, and parietal [Pz]) and left and right tem-
poral sites (T3 and T4) by use of linked ear electrodes as
a reference while subjects performed a two-tone–discrimi-
nation task. The electroencephalogram was amplified by
10,000# and had a bandwidth of 0.16–30 Hz (3 dB),
and data were sampled at a rate of 250 Hz by an analog-
to-digital converter with 12-bit resolution. The data
sweep was 244 ms prestimulus and 752 ms poststimulus.
Tone pips of 20 ms duration at 1,000 Hz (frequent) and
1,500 Hz (rare), with a probability (frequent:rare) of 10:
1, were delivered binaurally at 75 dB (sound-pressure
level) and interstimulus interval of 1.1 s. Subjects were
instructed to count silently the high-pitched tones. The
P300 latency (in ms) was measured via the least-mean-
squares (LMS) method (Glabus et al. 1994), and ampli-
tude (in mV) was defined as the highest point in a pre-
defined window (280–550 ms). The Pz site was chosen
for all analyses. Table 2 shows that translocation carriers
were similar to patients with schizophrenia but differed
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Table 2
P300 Latency and P300 Amplitude in the Family with the
Translocation, in Patients with Schizophrenia, and in Controls
GROUP
MEAN (SD) OF P300
Latency
(ms)
Amplitude
(mV)
Relatives:
With translocation ( )np 12 366.2 (41.8) 6.8 (3.4)
With normal karyotype ( )np 10 338.3 (34.5) 12.1 (3.5)
Patients with schizophrenia ( )np 20 391.3 (47.2) 7.2 (4.0)
Controls ( )np 26 354.8 (26.5) 11.0 (3.1)
NOTE.—Results were determined by multivariate analysis of vari-
ance. There was a group effect for latency ( , ,Fp 5.62 dfp 3 Pp
) and for amplitude ( , , ). Scheffe post.002 Fp 8.62 dfp 3 Pp .0001
hoc comparisons of means showed significant differences between
groups, in P300 latency (controls ! patients with schizophrenia,
; relatives with a normal karyotype ! patients with schizo-Pp .02
phrenia, ) and in P300 amplitude (controls 1 patients withPp .007
schizophrenia, ; controls 1 relatives with the translocation,Pp .007
; relatives with a normal karyotype 1 patients with schizo-Pp .01
phrenia, ; relatives with a normal karyotype 1 relatives withPp .007
the translocation, ).Pp .009
significantly from noncarriers and controls, in measures
of P300 amplitude and of P300 latency. Analysis of P300
amplitude showed the following: controls 1 patients with
schizophrenia, ; controls 1 relatives with thePp .007
translocation, ; relatives with a normal karyotypePp .01
1 patients with schizophrenia, ; and relativesPp .007
with a normal karyotype 1 relatives with the transloca-
tion, . Analysis of P300 latency showed the fol-Pp .009
lowing: controls ! patients with schizophrenia, ;Pp .02
and relatives with a normal karyotype ! patients with
schizophrenia, . P300 amplitudes !2 SD belowPp .007
the control mean were recorded in 7 of the 12 relatives
with the translocation, and the diagnoses for these 7 sub-
jects were depression (in three cases), schizophrenia (in
two cases), and no symptoms (in two cases). Similarly,
for P300 latency, the two translocation carriers with la-
tency 12 SD above the control mean were a relative with
no psychiatric diagnosis and a relative with schizophrenia.
Significant changes in the amplitude and the latency of
P300 in translocation carriers were therefore not restricted
to subjects with a psychiatric diagnosis. The findings are
consistent with previous findings in other families with
multiple members with schizophrenia, in which the am-
plitude of and the latency of P300 appear to be trait
markers of risk, rather than state markers reflecting the
presence of symptoms (Blackwood et al. 1991; Sham et
al. 1994).
We have described elsewhere two genes, disrupted in
schizophrenia 1 (DISC1 [MIM 605210]) and disrupted
in schizophrenia 2 (DISC2), that are directly disrupted
by the breakpoint on chromosome 1, and a third gene,
translin-associated factor X (TSNAX [MIM 602964]),
that is in very close proximity (Millar et al. 2000). These
and other functionally related genes are strong candi-
dates for a role in the development of psychiatric dis-
orders. There are no genes close to the breakpoint on
11q14.3, making this the less-likely site for genes con-
tributing to psychosis in the family, although we cannot
entirely rule out the possibility that translocation has
long-range positional effects on gene expression.
Single large families with multiple affected members
have important advantages for the study of genetically
complex disorders such as the major psychoses, when
substantial locus heterogeneity is probable. A disadvan-
tage is that findings may be either rare or unique to one
family and, thus, not relevant to the disease itself. There
are, however, independent reports of suggestive linkage,
for both schizophrenia and bipolar disorder, with mark-
ers mapped close to the breakpoint on 1q42. The strong-
est independent support for linkage to the 1q42 break-
point region is from two studies of Finnish families with
schizophrenia. A genomewide scan of 134 affected sib-
ling pairs with schizophrenia revealed a maximum LOD
score of 2.6 with the marker D1S439, which lies !500
kb from the translocation breakpoint (Ekelund et al.
2000). In a second study, of 20 families with schizo-
phrenia that are from an isolated Finnish subpopulation,
Hovatta et al. (1999) reported a maximum LOD score
of 3.7 at 1q32-41, and there is overlap of the regions
showing linkage in these two Finnish populations. Link-
age between the microsatellite D1S103, which maps !1
Mb from the breakpoint, and bipolar disorder has been
reported in two separate studies: Gejman et al. (1993)
found suggestive linkage (LOD score 2.4) with D1S103
in 1 of 19 families with bipolar disorder, and LaBuda
et al. (1996) reported increased allele sharing (P !
), under one weighting function, in Old Order.0001
Amish families with bipolar disorder. Detera-Wadleigh
et al. (1999), reported, in a genomewide scan of 22 fam-
ilies with bipolar disorder, elevated identical-by-descent
sharing (maximum LOD score 2.3) in a 30-cM region
spanning 1q25-q42 and extending to the breakpoint re-
gion; it is noteworthy that, in 15 of these 22 families
with bipolar disorder, at least one individual was diag-
nosed with either schizophrenia or schizoaffective dis-
order. The breakpoint on 1q42 is ∼60 cM from the locus
on 1q21-q22, where linkage to schizophrenia has also
been reported (Brzustowicz et al. 2000; Gurling et al.
2001), and this breakpoint appears to be a separate locus
related to schizophrenia.
Some genetic risk factors for psychoses may contribute
to a range of symptoms that cross traditional diagnostic
boundaries, and the locus identified by the breakpoint on
1q42 appears to be implicated in families with either
schizophrenia or bipolar disorder. The range of diagnoses
recorded in the family with the translocation is found in
other extended families with schizophrenia (St. Clair et
al. 1989). Similarly, the observation that, in the family
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with the translocation, P300 amplitude and P300 latency
are abnormal in individuals with psychoses and in their
asymptomatic relatives is similar to the pattern of P300
changes in other families with multiple members with
schizophrenia and may provide clues to the biological
basis for the varied clinical presentations in these families.
For example, reduction of P300 amplitude in patients
with schizophrenia and in their relatives has been cor-
related with reduced regional perfusion, as measured by
single-proton-emission computed tomography, in left-
frontal regions (Blackwood et al. 1999) and with re-
duced gray-matter volume of the left-superior temporal
gyrus, as measured by positron-emission tomography
(O’Donnell et al. 1999). Genetic markers combined with
other investigative approaches—including neurophy-
siology, brain imaging, and neuropsychology—may help
to define subtypes of the psychoses.
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